Antibody-peptide fusions challenge ADCs for therapeutic throne

About Events Advertise Stay Updated Stay Updated Partnering Related Topics Licensing M&A Growth Strategy Recent in Partnering See All Partnering Ipsen pens $800m Memo for kidney transplant patients Ipsen pens $800m Memo for kidney transplant patients by Nnenna Ohaka Jul 3, 2026 2 Min Read Partnering When to say when: Stepping down as a HLTHcare founder When to say when: Stepping down as a HLTHcare founder by Nnenna Ohaka Jul 2, 2026 4 Min Read Investment Related Topics VC/PE Seed Funding IPOs Recent in Investment See All Investment The mega-round mindset: How biotechs are thinking bigger and raising smarter The mega-round mindset: How biotechs are thinking bigger and raising smarter by Millie Nelson Jul 3, 2026 4 Min Read Investment BMS-backed Beeline expands Series A 42% to $426.3m BMS-backed Beeline expands Series A 42% to $426.3m by Millie Nelson Jul 1, 2026 2 Min Read Modalities Related Topics Nucleic Acids Antibodies and Peptides Advanced Therapies Recent in Modalities See All Modalities Antibody-peptide fusions challenge ADCs for therapeutic throne Antibody-peptide fusions challenge ADCs for therapeutic throne by Millie Hoe , Søren Hough Jul 3, 2026 6 Min Read Partnering Ipsen pens $800m Memo for kidney transplant patients Ipsen pens $800m Memo for kidney transplant patients by Nnenna Ohaka Jul 3, 2026 2 Min Read Business Strategy Related Topics Compliance, Regulatory and Legal Access and Channel Finance and Accounting Clinical Trials Pricing and Contracting Recent in Business Strategy See All Clinical Trials Caidya, Simbec-Orion form specialty CRO Caidya, Simbec-Orion form specialty CRO Jul 1, 2026 1 Min Read Access and Channel Pharma patient support programs shift in-house Pharma patient support programs shift in-house Jun 30, 2026 1 Min Read Modalities Antibodies and Peptides News Antibody-peptide fusions challenge ADCs for therapeutic throne ATB Therapeutics’ fusions are tackling blood cancers, solid tumors, and autoimmune disorders.